Matthias Stelljes
- Hematology top 0.2%
- Hematopoietic Stem Cell Transplantation 83
- Acute Myeloid Leukemia Research 78
- Chronic Myeloid Leukemia Treatments 52
- Oncology top 0.5%
- CAR-T cell therapy research 51
-
- Acute Lymphoblastic Leukemia research 105
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 24
-
- Lymphoma Diagnosis and Treatment 28
-
- Immune Cell Function and Interaction 19
Matthias Stelljes
194 papers receiving 6.0k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Hematology 3.0k
- Oncology 2.9k
- Public Health, Environmental and Occupational Health 2.9k
- Genetics 647
- Pathology and Forensic Medicine 960
Countries citing papers authored by Matthias Stelljes
This map shows the geographic impact of Matthias Stelljes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Stelljes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Stelljes more than expected).
Fields of papers citing papers by Matthias Stelljes
This network shows the impact of papers produced by Matthias Stelljes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Stelljes. The network helps show where Matthias Stelljes may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Matthias Stelljes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 13 | |
| 7 | 2024 | 6 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 3 | |
| 10 | 2023 | 0 | |
| 11 | 2023 | 0 | |
| 12 | 2023 | 8 | |
| 13 | 2023 | 9 | |
| 14 | 2023 | 5 | |
| 15 | 2021 | 29 | |
| 16 | 2021 | 3 | |
| 17 | 2019 | 51 | |
| 18 | 2018 | 41 | |
| 19 | 2017 | 5 | |
| 20 | 2017 | 1 |
About Matthias Stelljes
Matthias Stelljes is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health, having authored 208 papers that have together received 6.1k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (105 papers), Hematopoietic Stem Cell Transplantation (83 papers), Acute Myeloid Leukemia Research (78 papers), Chronic Myeloid Leukemia Treatments (52 papers), CAR-T cell therapy research (51 papers), Lymphoma Diagnosis and Treatment (28 papers), Chronic Lymphocytic Leukemia Research (24 papers) and Immune Cell Function and Interaction (19 papers). The work is most often cited by research in Hematology (3.0k citations), Oncology (2.9k citations) and Public Health, Environmental and Occupational Health (2.9k citations). Matthias Stelljes has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Nicola Gökbuget, Hagop M. Kantarjian, Erik Vandendries, Anjali S. Advani, Daniel J. DeAngelo, Wendy Stock, Dieter Hoelzer, Susan O’Brien, Michaela Liedtke and Barbara Sleight. Their work appears in journals such as Blood, Bone Marrow Transplantation, Journal of Clinical Oncology, Cancer and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.